Epigenetics & Chromatin

Scope & Guideline

Illuminating the Complexities of Chromatin

Introduction

Explore the comprehensive scope of Epigenetics & Chromatin through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Epigenetics & Chromatin in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationEPIGENET CHROMATIN / Epigenetics Chromatin
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal 'Epigenetics & Chromatin' is dedicated to advancing the understanding of epigenetic mechanisms and their impacts on chromatin dynamics, gene expression, and cellular processes. Its core aims are rooted in providing a platform for innovative research that explores the interplay between genetics and epigenetics across various biological contexts.
  1. Epigenetic Regulation Mechanisms:
    The journal focuses on elucidating the complex mechanisms of epigenetic regulation, including DNA methylation, histone modifications, and chromatin remodeling, which are crucial for gene expression and cellular identity.
  2. Chromatin Structure and Dynamics:
    Research published in the journal often investigates the organization and dynamics of chromatin, including the roles of chromatin-associated proteins, nuclear architecture, and higher-order chromatin structures in regulating genetic information.
  3. Disease Associations and Therapeutics:
    There is a consistent emphasis on the links between epigenetic alterations and various diseases, particularly cancer. The journal encourages studies that explore therapeutic interventions targeting epigenetic modifications.
  4. Model Organisms and Systems Biology:
    The journal includes studies using diverse model organisms ranging from yeast and zebrafish to mammals, reflecting a broad interest in how epigenetic principles apply across species and their relevance to human health.
  5. Technological Advancements in Epigenomics:
    The journal highlights innovative methodologies and technologies in epigenomics, such as CRISPR-based epigenome editing, high-resolution chromatin profiling, and single-cell analyses, contributing to the advancement of the field.
The journal 'Epigenetics & Chromatin' has shown a dynamic evolution in its focus areas, reflecting contemporary trends and emerging themes in epigenetic research. Recent publications highlight several key themes that are gaining traction and relevance within the scientific community.
  1. Environmental Epigenetics:
    There is a growing interest in how environmental factors, such as pollutants and dietary components, influence epigenetic modifications and contribute to disease risk, marking a significant trend towards understanding the interplay between environment and epigenetics.
  2. Epigenetic Editing Technologies:
    Research on novel epigenetic editing technologies, including CRISPR-based approaches, has surged, emphasizing their potential for therapeutic applications and functional studies of epigenetic regulation.
  3. Longitudinal and Developmental Studies:
    Emerging studies focus on the epigenetic landscape during development and aging, exploring how epigenetic changes over time influence health outcomes and disease susceptibility, particularly in the context of early-life exposures.
  4. Integration of Multi-Omics Approaches:
    The trend towards integrating multi-omics techniques, such as combining epigenomics with transcriptomics and proteomics, is evident, providing a comprehensive understanding of cellular processes and disease mechanisms.
  5. Role of Non-Coding RNAs in Epigenetic Regulation:
    There is an increasing exploration of the role of non-coding RNAs in modulating epigenetic landscapes, highlighting their significance in gene regulation and potential therapeutic targets.

Declining or Waning

While 'Epigenetics & Chromatin' continues to expand its focus on emerging themes, certain areas have seen a decline in prominence in recent publications. This shift indicates changing research priorities and evolving methodologies within the field.
  1. Basic Biochemical Mechanisms of Epigenetic Enzymes:
    Research that solely focuses on the biochemical characterization of epigenetic enzymes has decreased, as the journal now favors studies that integrate these mechanisms into broader biological contexts and disease implications.
  2. Historical Perspectives on Epigenetics:
    Papers that provide historical analyses or reviews of epigenetic concepts have become less frequent, suggesting a shift towards more contemporary research that addresses current challenges and innovations in the field.
  3. Single Aspects of Epigenetic Regulation:
    There is a noticeable reduction in studies examining single aspects of epigenetic regulation in isolation, such as individual histone modifications without consideration of their interactions or comprehensive effects on gene regulation.
  4. General Surveys of Epigenetic Phenomena:
    The journal has moved away from general surveys or overviews of epigenetic phenomena, favoring detailed, hypothesis-driven research that provides novel insights and data.

Similar Journals

MOLECULAR BIOLOGY

Connecting Researchers to the Heart of Molecular Biology
Publisher: PLEIADES PUBLISHING INCISSN: 0026-8933Frequency: 6 issues/year

MOLECULAR BIOLOGY, published by PLEIADES PUBLISHING INC, serves as a vital repository for the dissemination of innovative research within the fields of biochemistry, genetics, and molecular biology. With an ISSN of 0026-8933 and an E-ISSN of 1608-3245, this journal has been a mainstay in the scientific community since its inception, embracing its deep historical roots from 1971 to the present. Recognized for its qualitative contributions, MOLECULAR BIOLOGY is ranked in the Q3 quartile for Biophysics and Q4 for Structural Biology, placing it among select journals in its domain. Researchers and students alike benefit from its rigorous peer-reviewed articles, which focus on all aspects of molecular mechanisms and interactions. The journal's inclusion in prestigious databases underlines its commitment to academic excellence. The editorial board is dedicated to fostering the sharing of influential findings, making it an essential resource for advancing knowledge and innovation in molecular biology.

DEVELOPMENTAL CELL

Pioneering Research in Cell and Developmental Biology
Publisher: CELL PRESSISSN: 1534-5807Frequency: 12 issues/year

DEVELOPMENTAL CELL, published by CELL PRESS, stands as a premier journal in the fields of Biochemistry, Genetics and Molecular Biology, Cell Biology, and Developmental Biology. With a significant influence evidenced by its Q1 rankings across several categories in 2023 and a remarkable Scopus ranking placing it at the 98th percentile for Developmental Biology, this journal is pivotal for researchers and academics aiming to advance their understanding of cellular processes. Covering a broad range of topics from molecular mechanisms to cellular developmental pathways, DEVELOPMENTAL CELL publishes cutting-edge research articles that contribute to the dynamic landscape of cell biology and related disciplines. Although it does not currently offer open access, the journal is accessible through institutional subscriptions, reinforcing its commitment to disseminating high-quality scientific knowledge produced by leading experts in the field. Based in the United States, DEVELOPMENTAL CELL continues to push the boundaries of discovery and innovation in life sciences, making it an essential resource for professionals, researchers, and students alike in the quest for foundational biological insights.

GENE EXPRESSION PATTERNS

Advancing Knowledge in Molecular Biology
Publisher: ELSEVIERISSN: 1567-133XFrequency: 4 issues/year

GENE EXPRESSION PATTERNS, published by Elsevier, is a peer-reviewed academic journal specializing in the field of developmental biology, genetics, and molecular biology. With the ISSN 1567-133X and E-ISSN 1872-7298, it has been a crucial platform for researchers since its inception in 2001. Although classified in the Q4 quartile across its relevant categories for 2023, the journal plays an essential role in disseminating innovative studies that shed light on intricate gene expression mechanisms. Located in Amsterdam, Netherlands, the journal aims to provide a comprehensive understanding of gene regulation through rich analyses and original studies, thus appealing to a wide audience, including esteemed researchers, dedicated professionals, and enthusiastic students in the biomedical arena. Access to this journal is not open, which underscores the necessity of institutional subscriptions for full articles, reinforcing its targeted dissemination of specialized knowledge in gene expression.

EMBO JOURNAL

Pioneering transformative research in life sciences.
Publisher: WILEYISSN: 0261-4189Frequency: 24 issues/year

The EMBO JOURNAL, published by Wiley in Germany, is a renowned scientific journal that has been at the forefront of research in the fields of biochemistry, genetics, and molecular biology since its inception in 1982. With an impressive convergence of contributions leading up to 2024, this journal is recognized for its high impact, reflected in its Q1 rankings across multiple categories including Immunology, Molecular Biology, and Neuroscience. It holds a prestigious place in the academic community, standing out with an exemplary Scopus ranking of #3 in General Immunology and Microbiology and #6 in General Neuroscience, making it a critical resource for researchers, professionals, and students alike. The journal aims to publish transformative research that sheds light on the underlying mechanisms of biological processes, thus advancing our understanding of health and disease. While currently not offering open access, the EMBO JOURNAL continues to facilitate a rich exchange of knowledge through its rigorous peer-review process and commitment to excellence.

Journal of Genetics and Genomics

Advancing Knowledge in Genetics and Genomics
Publisher: SCIENCE PRESSISSN: 1673-8527Frequency: 12 issues/year

The Journal of Genetics and Genomics, published by SCIENCE PRESS in China, stands as a significant contributor to the fields of Genetics and Molecular Biology. With an ISSN of 1673-8527 and E-ISSN 1873-5533, this esteemed journal has achieved a remarkable reputation, holding a prestigious Q1 ranking in both Genetics and Molecular Biology as of 2023. This journal not only showcases pioneering research but also fosters vital discussions on contemporary challenges and innovations within genomic sciences. As part of its commitment to facilitating scientific advancement, the journal encompasses a range of research articles, reviews, and short communications, all aiming to illuminate the complexities of genetic structures and functions from 2007 to 2024. Researchers, professionals, and students alike are encouraged to engage with its content, which ranks favorably in Scopus—placing it within the top tier of its categories. Join the community of academic excellence and explore the latest findings that shape our understanding of genomics.

GENOME

Illuminating Pathways in Genetic Research
Publisher: CANADIAN SCIENCE PUBLISHINGISSN: 0831-2796Frequency: 12 issues/year

GENOME is a leading peer-reviewed journal published by Canadian Science Publishing, dedicated to advancing the field of genetics, biotechnology, and molecular biology. With a strong commitment to disseminating high-quality research, GENOME has earned a reputable spot in the academic community, boasting a Q2 classification in Biotechnology and Medicine (miscellaneous), and a Q3 rank in Genetics and Molecular Biology for 2023. The journal, identified by its ISSN 0831-2796 and E-ISSN 1480-3321, publishes innovative studies that span from 1987 to 2024, ensuring a rich historical context while addressing contemporary challenges in the field. Researchers and professionals are encouraged to contribute and engage with content that shapes the landscape of genetic research. Although the journal does not currently provide open access, it remains a vital resource for those committed to the exploration of genomic sciences, making it an essential read for both seasoned researchers and students alike.

GENES TO CELLS

Transforming Understanding of Cellular Mechanisms and Genetics
Publisher: WILEYISSN: 1356-9597Frequency: 12 issues/year

GENES TO CELLS is a distinguished peer-reviewed journal published by Wiley, offering valuable insights into the intricate world of cell biology and genetics. With an ISSN of 1356-9597 and an E-ISSN of 1365-2443, this journal has been contributing to the academic community since its inception in 1996 and will continue its publishing journey until 2024. Recognized with a category quartile ranking of Q3 in both Cell Biology and Genetics, and Q2 in Medicine (Miscellaneous) as of 2023, it serves as an important platform for disseminating innovative research and reviews in molecular biology and related fields. Although it does not currently offer open access, the journal caters to a diverse readership by providing comprehensive studies that are essential for professionals, researchers, and students aiming to deepen their understanding of genetic mechanisms and cellular functions. Situated in the United Kingdom, GENES TO CELLS continues to play a pivotal role in shaping the future of biological research.

Epigenetics

Advancing Insights into the Epigenetic Frontier
Publisher: TAYLOR & FRANCIS INCISSN: 1559-2294Frequency: 12 issues/year

Epigenetics, published by Taylor & Francis Inc, is a leading journal in the fields of Cancer Research, Medicine (miscellaneous), and Molecular Biology. With an ISSN of 1559-2294 and an E-ISSN of 1559-2308, this journal has been paving the way for groundbreaking research since its inception in 2006, and it continues to play a crucial role in advancing our understanding of epigenetic mechanisms and their implications in health and disease. The journal is highly regarded, ranking in the Q1 category for Medicine and Q2 for both Cancer Research and Molecular Biology according to the 2023 category quartiles. Researchers and professionals in the field will find invaluable insights and innovative studies within its pages, making it an essential resource for those engaged in cutting-edge research. Although the journal is not open access, it encourages a comprehensive understanding through high-quality peer-reviewed content. With its creative exploration of the epigenetic landscape, Epigenetics serves as a vital platform for the sharing of knowledge that could lead to breakthroughs in treatments and therapies.

CURRENT GENETICS

Illuminating Pathways in Molecular Biology
Publisher: SPRINGERISSN: 0172-8083Frequency: 4 issues/year

CURRENT GENETICS is a prestigious journal published by SPRINGER, dedicated to advancing the field of genetics through the dissemination of high-quality research. With a notable impact factor and ranking in the Q2 category for both Genetics and Medicine (miscellaneous) as of 2023, it firmly establishes itself as a significant resource for the academic community. The journal’s comprehensive scope explores the latest findings in genetic research, along with accompanying interdisciplinary studies, providing a platform for researchers to share innovative ideas and methodologies. ISSN: 0172-8083, E-ISSN: 1432-0983, stands testament to its commitment to scholarly excellence. While Open Access options are not currently available, CURRENT GENETICS remains accessible to a broad audience, promoting a rich exchange of knowledge that supports the vast and evolving discipline of genetics. Since its inception in 1979 and through its converged years till 2024, this journal has played a crucial role in confronting scientific challenges and promoting advancements in genomic medicine and molecular biology. As such, it is an essential read for researchers, professionals, and students keen to remain at the forefront of genetic research.

CURRENT OPINION IN GENETICS & DEVELOPMENT

Exploring the frontiers of developmental biology.
Publisher: CURRENT BIOLOGY LTDISSN: 0959-437XFrequency: 6 issues/year

CURRENT OPINION IN GENETICS & DEVELOPMENT is a prestigious journal published by CURRENT BIOLOGY LTD that offers an insightful platform for the latest developments and emerging trends in the fields of genetics and developmental biology. Established in 1991 and set to continue until at least 2024, this journal achieves notable recognition in the academic community with a Q1 classification in both its major categories as of 2023. With a Scopus rank placing it within the top quartile for both genetics and developmental biology, it serves as an essential resource for researchers, professionals, and students seeking to enhance their understanding of genetic mechanisms and developmental processes. While currently not an open-access journal, readers can explore the collection of high-quality articles that contribute to shaping contemporary scientific discourse and fostering innovation within these dynamic fields. For those dedicated to advancing their research and knowledge, CURRENT OPINION IN GENETICS & DEVELOPMENT stands as a vital and influential academic publication.